In the GLP-1 cohort, diabetes was present in 198 patients (71.5%), hypertension in 162 patients (58.5%), hyperlipidemia in 98 patients (35.4%), cardiovascular disease in 53 patients (19.1%), kidney disease in 46 patients (16.6%), and anxiety in 34 patients (12.3%). Here, GLP1R is linked to diabetes mellitus.